Apr 032020
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, MA – Akouos, Inc., a precision genetic medicine company developing potential gene therapies to restore, improve or preserve hearing, today announced it has raised $105 million in an oversubscribed Series B financing led by Pivotal bioVenture Partners, with participation from new investors Cormorant Asset Management, Cowen Healthcare Investments, ...

Akouos adds Dr Vicki Sato and Dr Heather Preston to Board along with raising $105m Series B financing led by Pivotal bioVenture

Akouos adds Dr Vicki Sato and Dr Heather Preston to Board along with raising $105m Series B financing led by Pivotal bioVenture

From:: Akouos adds Dr Vicki Sato and Dr Heather Preston to Board along with raising $105m Series B financing led by Pivotal bioVenture

Sorry, the comment form is closed at this time.